Publication

Article

Supplements and Featured Publications

Diagnosis and Trial Options in Sarcoma
Volume1
Issue 1

Exploring the Interaction of MDM2 and p53 in Soft Tissue Sarcomas

Articles in this issue
Javier Martin-Broto, MD, PhD,
Dr. Martin-Broto on Future Research Directions of Soft Tissue Sarcoma
Exploring the Interaction of MDM2 and p53 in Soft Tissue Sarcomas
Exploring the Interaction of MDM2 and p53 in Soft Tissue Sarcomas
Jean-Yves Blay, MD
Dr. Blay on Treatment Considerations in Soft Tissue Sarcomas
Patricia LoRusso, DO
Dr. LoRusso on the Benefit of Genetic Sequencing in Sarcomas
Javier Martin-Broto, MD, PhD
Dr. Martin-Broto on the Current First-Line Treatment of Soft Tissue Sarcomas
Javier Martin-Broto, MD, PhD
Dr. Martin-Broto on MDM2 and P53 in Soft Tissue Sarcoma
Javier Martin-Broto, MD, PhD
Dr. Martin-Broto on the Ongoing Research of MDM2 Agonists in Soft Tissue Sarcoma
Patricia LoRusso, DO
MDM2 Pulls Novel Treatments Into Focus for Underserved Liposarcoma Population
Patricia LoRusso, DO
Dr. LoRusso on the Importance of Clinical Trials in MDM2-Amplified Dedifferentiated Liposarcoma
Jean-Yves Blay, MD
Dr. Blay on the Current Treatment Challenges in Soft Tissue Sarcomas
Patricia LoRusso, DO
Dr. LoRusso on the Efficacy of BI 907828 in Solid Tumors
Jean-Yves Blay, MD
Dr. Blay on the Exploration of BI 907828 in Patients With Sarcoma
Related Videos
John H. Strickler, MD
Brandon G. Smaglo, MD, FACP
Cedric Pobel, MD
Ruth M. O’Regan, MD
Related Content
lertsakwiman– stock.adobe.com
November 21st 2024

Afami-Cel Shows Durable Persistence and Tumor-Killing Abilities in Synovial Sarcoma

Susana M. Campos, MD, MPH
November 21st 2024

Trastuzumab Deruxtecan Advances HER2+ Gynecologic Cancer Care: With Susana M. Campos, MD, MPH

Dana-Farber Cancer Institute Faculty Among Highly Cited Researchers | Image Credit: © Cornflakesei - stock.adobe.com
November 21st 2024

Dana-Farber Cancer Institute Faculty Among World's Most Highly Cited Researchers for 2024

D. Ross Camidge, MD, PhD; Rahul Gosain, MD, MBA, medical director, Wilmot Cancer Institute at Webster, director, Wilmot Cancer Institute Regional Infusion services, assistant professor, clinical medicine, Department of Medicine, Hematology/Oncology, University of Rochester
November 20th 2024

How the Drive to Connect the Oncology Community Built an Educational Podcast Platform: With D. Ross Camidge, MD, PhD; and Rahul Gosain, MD, MBA

FDA
November 21st 2024

FDA Accepts sNDA for Darolutamide Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer

Jorge E. Cortes, MD, of Georgia Cancer Center
November 21st 2024

An Era of Firsts in CML: Asciminib Challenges SOC TKIs